Baker Brothers Advisors - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q3 2023$74,500,526
+3.5%
2,691,4930.0%0.43%
+2.9%
Q2 2023$71,997,438
+23.5%
2,691,4930.0%0.42%
+31.5%
Q1 2023$58,297,738
+1001.3%
2,691,493
+1111.2%
0.32%
+890.6%
Q4 2022$5,293,328
+20.8%
222,2220.0%0.03%
+10.3%
Q3 2022$4,382,000
+1.2%
222,2220.0%0.03%
+16.0%
Q2 2022$4,331,000
-23.6%
222,2220.0%0.02%
-24.2%
Q1 2022$5,669,000
+1.4%
222,2220.0%0.03%
+22.2%
Q4 2021$5,593,000
-8.5%
222,2220.0%0.03%0.0%
Q3 2021$6,113,000
-13.3%
222,2220.0%0.03%
-12.9%
Q2 2021$7,053,000
-30.8%
222,2220.0%0.03%
-29.5%
Q1 2021$10,196,000222,2220.04%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 4,839,529$133,958,16340.59%
Column Group LLC 1,230,641$34,064,14322.62%
Boxer Capital, LLC 4,684,264$129,660,4286.90%
Finepoint Capital LP 427,000$11,819,3605.89%
Casdin Capital, LLC 1,810,000$50,100,8005.54%
EcoR1 Capital, LLC 5,577,863$154,395,2485.21%
DAFNA Capital Management LLC 473,394$13,103,5464.08%
Artal Group S.A. 2,529,737$70,0233.00%
BVF INC/IL 3,981,212$110,199,9482.97%
Bellevue Group AG 4,721,500$130,691,1202.11%
View complete list of REVOLUTION MEDICINES INC shareholders